BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹33 Cr | ₹40 Cr | ₹41 Cr | ₹29 Cr | ₹25 Cr |
What is the latest Net Current Assets ratio of BAFNA PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹29 Cr |
| Mar2021 | ₹25 Cr |
How is Net Current Assets of BAFNA PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | -17.16 | |
| Mar2024 | ₹40 Cr | -2.81 | |
| Mar2023 | ₹41 Cr | 41.46 | |
| Mar2022 | ₹29 Cr | 13.83 | |
| Mar2021 | ₹25 Cr | - | |
Compare Net Current Assets of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹589.7 Cr | 7% | 29.6% | 223.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 7% |
29.6% |
223.2% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses